Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-02 Sale | 2024-08-05 4:25 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 688 | $20.14 | $13,857 | 219,179 (Direct) | View |
2023-09-01 Sale | 2023-09-05 4:24 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 883 | $21.82 | $19,265 | 99,650 (Direct) | View |
2023-08-02 Sale | 2023-08-04 4:02 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,144 | $30.25 | $34,607 | 100,533 (Direct) | View |
2023-03-03 Sale | 2023-03-07 4:51 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 5,505 | $76.16 | $419,257 | 101,310 (Direct) | View |
2023-03-02 Sale | 2023-03-06 4:40 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,055 | $75.28 | $79,418 | 106,815 (Direct) | View |
2023-03-01 Sale | 2023-03-02 4:55 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 2,198 | $76.36 | $167,845 | 135,676 (Direct) | View |
2022-09-02 Sale | 2022-09-06 5:15 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 885 | $79.04 | $69,948 | 72,376 (Direct) | View |
2022-03-08 Sale | 2022-03-09 4:51 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 759 | $70.1 | $53,206 | 60,848 (Direct) | View |
2022-03-03 Sale | 2022-03-07 6:26 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,705 | $73.16 | $124,744 | 104,411 (Direct) | View |
2021-11-02 Sale | 2021-11-03 4:11 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 209 | $107.28 | $22,421 | 41,758 (Direct) | View |
2021-09-02 Sale | 2021-09-07 4:37 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 828 | $138.23 | $114,456 | 41,967 (Direct) | View |
2021-08-12 Sale | 2021-08-16 4:40 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 26,624 | $140.94 | $3,752,286 | 68,477 (Direct) | View |
2020-11-02 Sale | 2020-11-03 4:23 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 230 | $117.41 | $27,005 | 26,212 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-28 Option Award | 2024-08-06 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,286 | $12.24 | 220,465 (Direct) | View |
2024-02-27 Option Award | 2024-02-29 4:43 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 258,597 | $16.3 | 376,215 (Direct) | View |
2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 7,736 | $11.46 | 117,793 (Direct) | View |
2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A 2026-02-24 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 17,968 | $0 | 117,793 (Direct) | View |
2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 7,752 | $7.15 | 117,793 (Direct) | View |
2023-10-31 Exercise | 2023-11-02 4:20 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 2,480 | $11.44 | 117,793 (Direct) | View |
2023-06-30 Option Award | 2023-07-06 4:13 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 367 | $35.28 | 101,677 (Direct) | View |
2023-03-03 Option Award | 2023-03-06 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 11,808 | $0 | 106,815 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:55 pm | 2024-02-28 2033-02-27 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 39,614 | $76.97 | 135,676 (Direct) | View |
2023-02-28 Option Award | 2023-03-02 4:55 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 23,818 | $0 | 135,676 (Direct) | View |
2023-01-06 Option Award | 2023-01-10 4:18 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 66 | $62.3 | 74,442 (Direct) | View |
2022-12-02 Exercise | 2022-12-05 4:33 pm | N/A 2027-02-21 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 2,000 | $7.15 | 82,128 (Direct) | View |
2022-08-02 Option Award | 2022-08-03 4:45 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 7,122 | $70.2 | 73,261 (Direct) | View |
2022-07-05 Option Award | 2022-07-07 5:49 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 251 | $59.08 | 66,139 (Direct) | View |
2022-03-03 Exercise | 2022-03-11 4:55 pm | N/A 2026-02-24 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,200 | $11.46 | 73,624 (Direct) | View |
2022-03-03 Exercise | 2022-03-11 4:55 pm | N/A 2025-04-22 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 3,840 | $15.6 | 73,624 (Direct) | View |
2022-03-03 Option Award | 2022-03-07 6:26 pm | 2023-03-01 2032-02-29 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 42,804 | $80.59 | 104,411 (Direct) | View |
2022-03-03 Option Award | 2022-03-07 6:26 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 21,508 | $0 | 104,411 (Direct) | View |
2022-01-06 Option Award | 2022-01-12 5:37 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 46 | $63.82 | 41,804 (Direct) | View |
2021-08-12 Exercise | 2021-08-16 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 2,606 | $69.37 | 68,477 (Direct) | View |
2021-08-12 Exercise | 2021-08-16 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 2,767 | $32.02 | 68,477 (Direct) | View |
2021-08-12 Exercise | 2021-08-16 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 7,298 | $47.04 | 68,477 (Direct) | View |
2021-08-12 Exercise | 2021-08-16 4:40 pm | N/A 2025-04-22 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 36,624 | $0 | 68,477 (Direct) | View |
2021-08-12 Exercise | 2021-08-16 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 10,000 | $15.6 | 68,477 (Direct) | View |
2021-08-12 Gift | 2021-08-16 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,733 | $0 | 68,477 (Direct) | View |
2021-08-12 Exercise | 2021-08-16 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 5,927 | $19.25 | 68,477 (Direct) | View |
2021-08-12 Exercise | 2021-08-16 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 8,026 | $21.5 | 68,477 (Direct) | View |
2021-07-06 Option Award | 2021-07-08 5:35 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 100 | $137.12 | 35,993 (Direct) | View |
2021-03-04 Gift | 2021-03-08 4:23 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 910 | $0 | 36,658 (Direct) | View |
2021-03-02 Option Award | 2021-03-04 5:52 pm | N/A 2031-03-01 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 30,890 | $0 | 58,139 (Direct) | View |
2021-02-27 Exercise | 2021-03-02 4:14 pm | 2021-02-27 N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,465 | $0 | 27,677 (Direct) | View |
2021-02-27 Exercise | 2021-03-02 4:14 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,465 | $149.1 | 27,677 (Direct) | View |
Ownership | 2020-09-10 8:08 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 0 | $0 | 129,654 (Direct) | View |
2020-09-01 Option Award | 2020-09-04 4:38 pm | N/A 2030-08-31 | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 17,240 | $0 | 37,778 (Direct) | View |